Assembly Biosciences Picks Papkoff for Chief Scientific Officer

Xconomy Indiana — 

Assembly Biosciences (NASDAQ: ASMB) has appointed Jackie Papkoff senior vice president and chief scientific officer, microbiome. Papkoff most recently was a senior vice president for Cambridge, MA-based Evelo Biosciences. Carmel, IN-based Assembly is developing treatments for disorders associated with the human microbiome. Last year, Assembly began a collaboration agreement with Allergan (NYSE: AGN) to develop microbiome treatments for ulcerative colitis, Crohn’s disease, and other gastrointestinal disorders.